FFECT OF LIRAGLUTIDE ON CARDIOVASCULAR RISK FACTORS AND FUNCTION

Journal Title: Romanian Journal of Diabetes Nutrition and Metabolic Diseases - Year 2011, Vol 18, Issue 3

Abstract

Cardiovascular disease is the major cause of death in diabetes. This results from a cluster of risk factors, including high glucose, obesity, hypertension and dyslipidaemia. Liraglutide is the first native GLP-1 analogue and represents a breakthrough approach in type 2 diabetes treatment. Previous data from the LEAD™ programme have shown liraglutide to be a potent glucose regulator, but also to induce weight loss, lower blood pressure, and potentially show improvements in lipid levels, amongst other markers of cardiovascular risk. GLP-1 has also been shown to have an effect on the renal system, as well as the vascular system. Other cardio-protective effects of GLP-1 were proved in animal models: improves cardiac function in heart failure, functional recovery following myocardial ischemia, endothelium dysfunction, increases myocardial glucose uptake and reduces infarct size. Cardiovascular safety of liraglutide was assessed using existing clinical data. The incidence ratio for adjudicated broad/serious major adverse cardiovascular events (MACE) associated with liraglutide was 0.73 (95% CI 0.38–1.41) versus all comparator drugs, within cardiovascular safety limits defined by the United States Food & Drug Administration.

Authors and Affiliations

Maria Mota, Emiliana Mocan, Sorina Botescu

Keywords

Related Articles

Glucose Variability In Persons With Diabetes Evaluated By Continuous Glucose Monitoring

Blood glucose level is the main indicator of diabetes control. It is related to diabetes evolution and appearance of chronic complications. Daily and/or postprandial glucose fluctuations induce oxidative stress and endot...

THE RELATIONSHIP BETWEEN sE-Selectin CONCENTRATIONS, MICROALBUMINURIA AND INSULIN-SENSITIVITY IN TYPE 2 DIABETES PATIENTS

The aim of the study was to examine the effects of poor metabolic control on vascular endothelium, expressed by increased soluble E-selectin concentration, microalbuminuria and their relationship with insulin sensitivity...

The Impact Of An Educational Program In The Management Of Patients With Chronic Hepatitis C

Introduction: This study was designed to measure the impact of lifestyle changes, involving a diet therapy and physical exercises in patients with chronic hepatitis C (CHC). Methods: The study was conducted during Januar...

FEEDING, BIRTH WEIGHT AND RANK INFLUENCE ON THE RISK OF DIABETES MELLITUS IN CHILDREN

Background: The etiology of type 1 diabetes mellitus supposes the existence of genetic factors, but also environmental ones, of nutritional, fetal (e.g. birth weight) perinatal nature. This study aims at identifying food...

Download PDF file
  • EP ID EP113933
  • DOI -
  • Views 107
  • Downloads 0

How To Cite

Maria Mota, Emiliana Mocan, Sorina Botescu (2011). FFECT OF LIRAGLUTIDE ON CARDIOVASCULAR RISK FACTORS AND FUNCTION. Romanian Journal of Diabetes Nutrition and Metabolic Diseases, 18(3), 243-248. https://europub.co.uk/articles/-A-113933